Imatinib-Mesilate shortage — AU supply status & alternatives

Imatinib-Mesilate

—

In shortage · Australia

Imatinib-DRLA imatinib

In declared shortage · 🇦🇺 Australia

Critical shortage

Reading today’s signals…

✓ Can I substitute?

Per normal rules

Confirm with prescriber

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

Nov 2026

Sponsor est. via TGA

Product attributes reference data we hold

Active ingredient (INN)	Imatinib-Mesilate
Brand names	Imatinib-DRLA imatinib
Therapeutic category	Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper
Controlled substance	No

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Shortage status by regulator official notices

🇦🇺

Australia

TGA · 2h ago

High

Verified timeline regulator events

🇦🇺 1 Feb 2027

medium reported

🇦🇺 1 Sept 2026

medium reported

🇦🇺 31 July 2026

medium reported

🇦🇺 29 May 2026

high reported

Sources official regulators

🇦🇺

TGA

verified 2h ago

verify ↗

Mederti Drug Report

Generated 1 July 2026 · Australia market · 1 regulatory source

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.